Profile data is unavailable for this security.
About the company
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
- Revenue in USD (TTM)33.00bn
- Net income in USD4.29bn
- Incorporated2014
- Employees95.00k
- LocationMedtronic PLCBuilding Two Parkmore Business Park WestDUBLIN 1IrelandIRL
- Phone+353 14381700
- Websitehttps://www.medtronic.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Becton Dickinson and Co | 20.18bn | 1.73bn | 64.28bn | 73.00k | 37.44 | 2.48 | 16.02 | 3.19 | 5.94 | 5.94 | 69.42 | 89.64 | 0.3667 | 3.10 | 7.25 | -- | 3.14 | 2.55 | 3.66 | 2.93 | 45.36 | 45.29 | 8.56 | 7.31 | 0.7405 | 9.56 | 0.437 | 76.96 | 4.16 | 3.14 | 17.41 | 10.83 | -5.40 | 4.29 |
| Medtronic PLC | 33.00bn | 4.29bn | 107.87bn | 95.00k | 25.66 | 2.22 | 15.50 | 3.27 | 3.28 | 3.28 | 25.19 | 37.81 | 0.3664 | 2.03 | 5.41 | 347,326.30 | 4.80 | 4.57 | 5.47 | 5.14 | 65.46 | 66.75 | 13.10 | 13.49 | 1.39 | 9.82 | 0.3677 | 80.58 | 3.64 | 1.16 | -2.18 | -4.56 | 6.95 | 6.65 |
| Boston Scientific Corporation | 15.91bn | 1.79bn | 132.90bn | 48.00k | 74.54 | 6.42 | 43.96 | 8.35 | 1.21 | 1.21 | 10.73 | 14.05 | 0.4412 | 1.91 | 6.91 | 331,458.30 | 4.96 | 2.50 | 5.85 | 2.91 | 69.09 | 68.84 | 11.24 | 6.47 | 1.02 | 6.02 | 0.3419 | 0.00 | 12.29 | 7.71 | 144.55 | -0.4276 | 7.82 | -- |
| Stryker Corp | 21.97bn | 3.59bn | 147.03bn | 52.00k | 41.34 | 7.30 | 31.78 | 6.69 | 9.33 | 9.33 | 57.08 | 52.86 | 0.5368 | 1.56 | 6.27 | 422,576.90 | 8.77 | 6.60 | 10.76 | 7.84 | 63.88 | 63.99 | 16.34 | 13.13 | 1.22 | -- | 0.4345 | 43.70 | 11.11 | 8.55 | 34.22 | 9.68 | 0.1047 | 10.16 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 117.49m | 9.16% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 66.50m | 5.19% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 60.73m | 4.74% |
| Capital Research & Management Co. (Global Investors)as of 30 Sep 2024 | 32.63m | 2.54% |
| Geode Capital Management LLCas of 30 Sep 2024 | 26.48m | 2.07% |
| Massachusetts Financial Services Co.as of 30 Sep 2024 | 24.43m | 1.91% |
| JPMorgan Investment Management, Inc.as of 30 Sep 2024 | 21.10m | 1.65% |
| Wellington Management Co. LLPas of 30 Sep 2024 | 17.78m | 1.39% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 15.58m | 1.22% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 2024 | 15.54m | 1.21% |
